Arabic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
retinoic acid/سرطان
يتم حفظ الارتباط في الحافظة
الصفحة 1 من عند 76 النتائج
Inhibition of tumor necrosis factor by retinoic acid
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of immunology and the biochemistry of biological response modifiers. More specifically, the present invention relates to a novel method for the inhibition of tumor necrosis factor and nitric
Cellular retinoic acid binding protein II as a marker for breast cancer
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
FIELD OF THE INVENTION
The present invention relates to the diagnosis of breast cancer. It discloses the use of cellular retinoic acid binding protein II in the diagnosis of breast cancer. Furthermore, it especially relates to a method for diagnosis of breast cancer from a liquid sample, derived
Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
FIELD OF THE INVENTION
This invention is in the field of prevention and treatment of cancer. More specifically, this invention relates to the use of 9-cis-retinoic acids and derivatives thereof for treating cancers, in particular breast cancer. This invention also relates to the use of combinations
Transcription therapy for cancers
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of molecular biology of cancers. More specifically, the present invention relates to a method of transcription therapy for cancers.
2. Description of the Related Art
Acute promyelocytic
Tumor specific promoters of the midkine gene that allow for selective expression in P53-inactivated cells
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
TECHNICAL FIELD
The present invention relates to a tumor-specific promoter that permits the expression of foreign genes in tumor cells or tumor tissues in a tumor-specific manner. More specifically, it relates to a tumor-specific promoter that enables a high transcriptional activity in tumor cells
Dermal uses of trans-retinoids for the treatment of cancer
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to dermal uses of non-irritating retinoids and particularly to dermal uses of the esters and amides of certain stereoisomers of retinoic acid.
2. Description of the Prior Art
Chronic sun exposure has been determined to
9-cis retinoic acid esters and amides and uses thereof
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
BACKGROUND OF THE INVENTION
TECHNICAL FIELD
The present invention relates to the field of 9-cis retinoic acid and its esters and amides, and particularly to their uses for a variety of therapeutic and prophylactic treatments of the skin. The present invention particularly relates to 9-cis-retinoic
Aromatic retinoic acid analogues
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
DESCRIPTION
1. Technical Field
The invention is in the fields of retinoid chemistry and chemotherapy. More particularly, the invention relates to certain aromatic retinoic acid analogues.
2. Background Art
The progressive loss of the regulation of cellular differentiation by epithelial cells can
Reversing intestinal inflammation by inhibiting retinoic acid metabolism
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
BACKGROUND OF THE INVENTION
Pathological inflammation is emerging as an underlying mechanism for numerous diseases. For example, the major forms of idiopathic IBD, ulcerative colitis and Crohn's disease are chronic inflammatory disorders of the gastrointestinal tract. Animal studies have shown that
Reversing intestinal inflammation by inhibiting retinoic acid metabolism
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
BACKGROUND OF THE INVENTION
Pathological inflammation is emerging as an underlying mechanism for numerous diseases. For example, the major forms of idiopathic IBD, ulcerative colitis and Crohn's disease are chronic inflammatory disorders of the gastrointestinal tract. Animal studies have shown that
Reversing intestinal inflammation by inhibiting retinoic acid metabolism
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
BACKGROUND OF THE INVENTION
Pathological inflammation is emerging as an underlying mechanism for numerous diseases. For example, the major forms of idiopathic IBD, ulcerative colitis and Crohn's disease are chronic inflammatory disorders of the gastrointestinal tract. Animal studies have shown that
Open chain analogues of retinoic acid
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
DESCRIPTION
1. Technical Field
The invention is in the fields of retinoid chemistry and chemotherapy and relates to retinoic acid analogues. More particularly, the invention relates to certain retinoic acid analogues with open ring modifications.
2. Background Art
The progressive loss of the
Naphtenic and heterocyclic retinoic acid analogues
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
DESCRIPTION
1. Technical Field
The invention is in the fields of retinoid chemistry and chemotherapy. More particularly, the invention relates to certain naphthenic and heterocyclic retinoic acid analogues.
2. Background Art
The progressive loss of the regulation of cellular differentiation by
Naphthenic and heterocyclic retinoic acid analogues
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
REFERENCE TO GOVERNMENT GRANT OR CONTRACT
The invention described herein was made in the course of work under grant or contract from the National Institute of Health.
DESCRIPTION
1. Technical Field
The invention is in the fields of retinoid chemistry and chemotherapy. More particularly, the
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
BACKGROUND
For years, the cornerstones of cancer treatment have been surgery, chemotherapy, and radiation therapy. Over the last decade, targeted therapies--drugs that target cancer cells by homing in on specific molecular changes seen primarily in those cells--have also emerged as standard
قاعدة بيانات الأعشاب الطبية الأكثر اكتمالا التي يدعمها العلم
- يعمل في 55 لغة
- العلاجات العشبية مدعومة بالعلم
- التعرف على الأعشاب بالصورة
- خريطة GPS تفاعلية - ضع علامة على الأعشاب في الموقع (قريبًا)
- اقرأ المنشورات العلمية المتعلقة ببحثك
- البحث عن الأعشاب الطبية من آثارها
- نظّم اهتماماتك وابقَ على اطلاع دائم بأبحاث الأخبار والتجارب السريرية وبراءات الاختراع
اكتب أحد الأعراض أو المرض واقرأ عن الأعشاب التي قد تساعد ، واكتب عشبًا واطلع على الأمراض والأعراض التي تستخدم ضدها.
* تستند جميع المعلومات إلى البحوث العلمية المنشورة
